keyword
https://read.qxmd.com/read/37807568/h-61-towards-a-clinical-cultural-neuropsychological-science-a-case-study-of-a-bilingual-spanish-speaker-with-untreated-sleep-wake-disturbance
#21
JOURNAL ARTICLE
Alexandra Hernandez-Vallant, Naila Decruz-Dixon, Alexis Burks, Katie Edwards, Christina Gillezeau, Teagan Mullins, Kaitlyn Schodt, Macaiah Shendo, Lynette Abrams-Silva
OBJECTIVE: Access to neuropsychological services for bilingual individuals remains limited and more research is needed to clarify benefits of testing in both languages. Additionally, certain disorders remain underdiagnosed in the Hispanic/Latinx population. This case study describes the use of a comprehensive culturally and linguistically appropriate neuropsychological evaluation to leverage linguistic, cognitive, and social context to assist with establishing needed care and diagnostic clarity...
October 8, 2023: Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists
https://read.qxmd.com/read/37778242/characterizing-patterns-of-substance-use-in-trauma-exposed-youth
#22
JOURNAL ARTICLE
Shaunna L Clark, Cody G Dodd, Leslie Taylor, Sunita Stewart, Nancy Yang, Jeffrey D Shahidullah, Andrew G Guzick, Robyn Richmond, Nazan Aksan, Paul J Rathouz, Justin F Rousseau, D Jeffrey Newport, Karen Dineen Wagner, Charles B Nemeroff
OBJECTIVE: Previous work investigating the impact of childhood trauma on substance use and co-occurring psychiatric disorders has primarily been conducted in adults or on specific trauma types. This limits understanding of traumas impact in childhood and how different types of traumas play a role. We sought to characterize substance use in a sample of trauma-exposed youth in the context of psychiatric comorbidities. METHOD: 1152 youth from the Texas Childhood Trauma Research Network (TX-CTRN) that were exposed to at least one trauma meeting DSM-5 Criterion A were assessed for current substance use and psychiatric diagnoses...
September 25, 2023: Journal of Psychiatric Research
https://read.qxmd.com/read/37600902/retrospective-chart-review-of-substance-abuse-in-patients-with-psychiatric-emergencies-in-an-emerging-urban-county
#23
JOURNAL ARTICLE
Simran Koura, Avian White, Joshua Masdon, Kori L Brewer, Jennifer L Parker-Cote, William J Meggs
OBJECTIVES: Substance abuse is common in patients with psychiatric emergencies. To further understand the connection between substance abuse and psychiatric disorders, a retrospective chart review was done that included positive drug screens among patients with psychiatric emergencies and to determine whether there was an association between substances used and the psychiatric diagnosis. METHODS: A retrospective chart review of patients seen in an emergency department with psychiatric emergencies was conducted...
August 2023: Journal of the American College of Emergency Physicians open
https://read.qxmd.com/read/37582857/polygenic-contributions-to-performance-on-the-balloon-analogue-risk-task
#24
JOURNAL ARTICLE
E L Nurmi, C P Laughlin, H de Wit, A A Palmer, J MacKillop, T D Cannon, R M Bilder, E Congdon, F W Sabb, L C Seaman, J J McElroy, M R Libowitz, J Weafer, J Gray, A C Dean, G S Hellemann, E D London
Risky decision-making is a common, heritable endophenotype seen across many psychiatric disorders. Its underlying genetic architecture is incompletely explored. We examined behavior in the Balloon Analogue Risk Task (BART), which tests risky decision-making, in two independent samples of European ancestry. One sample (n = 1138) comprised healthy participants and some psychiatric patients (53 schizophrenia, 42 bipolar disorder, 47 ADHD); the other (n = 911) excluded for recent treatment of various psychiatric disorders but not ADHD...
August 15, 2023: Molecular Psychiatry
https://read.qxmd.com/read/37565344/compared-profile-of-late-onset-versus-childhood-onset-adhd-a-case-control-study-among-treatment-seeking-adult-patients
#25
JOURNAL ARTICLE
Lucie Jurek, Solène Montègue, Agathe Larrieu, Christophe Icard, Benjamin Rolland
OBJECTIVE: To compare the characteristics of childhood-onset versus late-onset Attention Deficit Hyperactivity Disorder (ADHD) in a sample of treatment-seeking patients. METHOD: Among total of 101 adult patients who were recently diagnosed for ADHD, using the Diagnostic Interview for Adult ADHD (DIVA 2.0), 56 subjects exhibited childhood-onset ADHD, versus 45 displayed late-onset ADHD. Both groups were compared according to their sociodemographic, clinical, and neuropsychological features, providing crude ( OR ) and adjusted odds ratios (aOR), and their 95% confidence intervals [95% CI]...
August 11, 2023: Journal of Attention Disorders
https://read.qxmd.com/read/37548880/longitudinal-examination-of-sexual-risk-behavior-in-college-students-with-and-without-attention-deficit-hyperactivity-disorder
#26
JOURNAL ARTICLE
Lisa Weyandt, George J DuPaul, Emily Shepard, Jeffrey D Labban, Alyssa Francis, Avery Beatty, Arthur D Anastopoulos
The present study sought to identify differences in the rates and predictors of risky sexual behavior among college students with and without attention-deficit hyperactivity disorder (ADHD). Current ADHD diagnosis, medication status among those with ADHD, executive functioning, substance use, comorbid anxiety, comorbid depression, and gender were identified as potential predictors of increased risky sexual behavior. Multiple group latent growth curve modeling was used to estimate trajectories of risky sexual behavior across four years of college among college students with ADHD (nmedicated  = 99, nunmedicated  = 105) and a comparison group (n = 217) recruited from colleges throughout the eastern United States (M age = 18...
August 7, 2023: Archives of Sexual Behavior
https://read.qxmd.com/read/37543051/a-systematic-review-of-cannabidiol-trials-in-neurodevelopmental-disorders
#27
REVIEW
Nina-Francecsa Parrella, Aron Thomas Hill, Peter Gregory Enticott, Pamela Barhoun, Isabella Simone Bower, Talitha Caitlyn Ford
Cannabis-derived compounds, such as cannabidiol (CBD) and delta-9-trans-tetrahydrocannabinol (THC), are increasingly prescribed for a range of clinical indications. These phyto-cannabinoids have multiple biological targets, including the body's endocannabinoid system. There is growing scientific interest in the use of CBD, a non-intoxicating compound, to ameliorate symptoms associated with neurodevelopmental disorders. However, its suitability as a pharmaceutical intervention has not been reliably established in these clinical populations...
September 2023: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/37503496/evaluation-of-efficacy-of-cannabis-use-in-patients-with-attention-deficit-hyperactivity-disorder-a-systematic-review
#28
REVIEW
Divyanshu Dhamija, Adedamola O Bello, Asma A Khan, Sai Dheeraj Gutlapalli, Mehvish Sohail, Priyansh A Patel, Sidharth Midha, Surmai Shukla, Lubna Mohammed
Cannabis is frequently used by people who self-medicate for the signs of mental health conditions. Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental illness, has been linked to increased cannabis use. However, compared to other mental disorders, cannabis use by people with ADHD has received much less research. The main goal of this systematic review was to understand the nature of the relationships between cannabis use and ADHD symptoms. We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct the systematic review...
June 2023: Curēus
https://read.qxmd.com/read/37467010/emotional-expression-on-social-media-support-forums-for-substance-cessation-observational-study-of-text-based-reddit-posts
#29
JOURNAL ARTICLE
Genevieve Yang, Sarah G King, Hung-Mo Lin, Rita Z Goldstein
BACKGROUND: Substance use disorder is characterized by distinct cognitive processes involved in emotion regulation as well as unique emotional experiences related to the relapsing cycle of drug use and recovery. Web-based communities and the posts they generate represent an unprecedented resource for studying subjective emotional experiences, capturing population types and sizes not typically available in the laboratory. Here, we mined text data from Reddit, a social media website that hosts discussions from pseudonymous users on specific topic forums, including forums for individuals who are trying to abstain from using drugs, to explore the putative specificity of the emotional experience of substance cessation...
July 19, 2023: Journal of Medical Internet Research
https://read.qxmd.com/read/37431426/mendelian-randomisation-studies-of-attention-deficit-hyperactivity-disorder
#30
JOURNAL ARTICLE
Lucy Riglin, Evie Stergiakouli
BACKGROUND: Observational studies have found Attention Deficit Hyperactivity Disorder (ADHD) to be associated with an increased risk of adverse outcomes as well as with early risk factors; however it is not clear whether these associations reflect causal effects. Alternatives to traditional observational studies are needed to investigate causality: one such design is Mendelian randomization (MR), which uses genetic variants as instrumental variables for the exposure. METHODS: In this review we summarise findings from approximately 50 studies using MR to examine potentially causal associations with ADHD as either an exposure or outcome...
December 2022: JCPP Adv
https://read.qxmd.com/read/37386438/attention-deficit-hyperactivity-disorder-adhd-symptoms-and-their-relation-to-diagnosed-adhd-sociodemographic-characteristics-and-substance-use-among-patients-receiving-opioid-agonist-therapy-a-norwegian-cohort-study
#31
JOURNAL ARTICLE
Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, Marianne Cook Pierron, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) symptoms may challenge sufficient treatment of substance use and mental disorders. The literature on the extent of such symptoms among patients receiving opioid agonist therapy (OAT) is scarce. This study examined ADHD symptoms using the ADHD self-report scale (ASRS) and the association between the 'ASRS-memory' and 'ASRS-attention' scores and substance use and sociodemographic characteristics among patients receiving OAT. METHODS: We used data from assessment visits of a cohort of patients in Norway...
June 29, 2023: BMC Psychiatry
https://read.qxmd.com/read/37346297/medicinal-cannabis-for-psychiatry-related-conditions-an-overview-of-current-australian-prescribing
#32
JOURNAL ARTICLE
Elizabeth A Cairns, Melissa J Benson, Miguel A Bedoya-Pérez, Sara L Macphail, Adith Mohan, Rhys Cohen, Perminder S Sachdev, Iain S McGregor
Objective: Evidence is accumulating that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders. Medicinal cannabis (MC) products are legally available for prescription in Australia, primarily through the Therapeutic Goods Administration (TGA) Special Access Scheme B (SAS-B). Here we investigated recent prescribing practices for psychiatric indications under SAS-B by Australian doctors. Methods: The dataset, obtained from the TGA, included information on MC applications made by doctors through the SAS-B process between 1st November 2016 and 30th September 2022 inclusive...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37237136/a-systematic-review-of-health-state-utility-values-and-psychometric-performance-of-generic-preference-based-instruments-for-children-and-adolescents-with-mental-health-problems
#33
REVIEW
Thao T H Thai, Lidia Engel, Joahna Kevin Perez, Eng Joo Tan, Sandra Eades, Lena Sanci, Cathrine Mihalopoulos
AIMS: This paper aims to systematically identify reported health state utility values (HSUVs) in children and adolescents with mental health problems (MHPs) aged less than 25 years; to summarise the techniques used to elicit HSUVs; and to examine the psychometric performance of the identified multi-attribute utility instruments (MAUIs) used in this space. METHODS: A systematic review was conducted following PRISMA guidelines. Peer-reviewed studies published in English, reporting HSUVs for children and adolescents with MHPs using direct or indirect valuation methods were searched in six databases...
May 26, 2023: Quality of Life Research
https://read.qxmd.com/read/37147797/exploring-the-link-between-attention-deficit-hyperactivity-disorder-and-cannabis-use-disorders-a-review
#34
REVIEW
Julia Helena Gujska, Andrzej Silczuk, Robert Madejek, Agata Szulc
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adults. In the substance use disorders (SUDs) population, ADHD prevalence reaches 23.1%, leading to more severe substance abuse progression and reduced treatment effectiveness. Cannabis is the most common illicit drug used among the ADHD population. The increasing popularity of medical marijuana (MM) has raised concerns about its potential impact on neurocognitive functions, particularly in adolescents...
May 6, 2023: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/37074466/genetic-network-structure-of-13-psychiatric-disorders-in-the-general-population
#35
JOURNAL ARTICLE
Hong Kyu Ihm, Hyejin Kim, Jinho Kim, Woong-Yang Park, Hyo Shin Kang, Jungkyu Park, Hong-Hee Won, Woojae Myung
Psychiatric disorders frequently co-occur and share common symptoms and genetic backgrounds. Previous research has used genome-wide association studies to identify the interrelationships among psychiatric disorders and identify clusters of disorders; however, these methods have limitations in terms of their ability to examine the relationships among disorders as a network structure and their generalizability to the general population. In this study, we explored the network structure of the polygenic risk score (PRS) for 13 psychiatric disorders in a general population (276,249 participants of European ancestry from the UK Biobank) and identified communities and the centrality of the network...
April 19, 2023: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/37059000/an-examination-of-the-effects-of-adhd-symptoms-and-sex-on-the-relation-between-cannabis-protective-behavioral-strategies-and-cannabis-consequences
#36
JOURNAL ARTICLE
Alison Looby, Mark A Prince, Nicholas R Livingston, Katherine A Berry
The risk for cannabis-related problems is elevated among young adults with attention-deficit/hyperactivity disorder (ADHD) symptoms. It is unknown whether the use of cannabis protective behavioral strategies (PBS) mitigates this risk for college students with ADHD. Prior research finds that college students who use alcohol and report high levels of ADHD symptoms particularly benefit from employing alcohol PBS, and these relations are strongest for male students. Thus, this study examined the moderating effects of ADHD symptoms and sex assigned at birth on the relation between cannabis PBS use and cannabis-related problems among college students who use cannabis...
April 8, 2023: Addictive Behaviors
https://read.qxmd.com/read/37042023/prenatal-alcohol-exposure-and-attention-deficit-hyperactivity-disorder-independently-predict-greater-substance-use-in-young-adulthood
#37
JOURNAL ARTICLE
Neil C Dodge, Joseph L Jacobson, Leslie H Lundahl, Sandra W Jacobson
BACKGROUND: The degree to which prenatal alcohol exposure (PAE) may influence alcohol and drug use in adulthood is difficult to determine, given that PAE is highly correlated with environmental factors, including low socioeconomic status and exposure to parental drinking, and with behavioral problems, such as, attention-deficit/hyperactivity disorder (ADHD), that are correlated with alcohol use and abuse. METHODS: Participants were 121 young adults from our Detroit Longitudinal Cohort study...
April 11, 2023: Alcoholism, Clinical and Experimental Research
https://read.qxmd.com/read/36981794/associations-between-prenatal-and-postnatal-exposure-to-cannabis-with-cognition-and-behavior-at-age-5-years-the-healthy-start-study
#38
JOURNAL ARTICLE
Brianna F Moore, Kaytlyn A Salmons, Adrienne T Hoyt, Karli S Swenson, Emily A Bates, Katherine A Sauder, Allison L B Shapiro, Greta Wilkening, Gregory L Kinney, Andreas M Neophytou, Cristina Sempio, Jost Klawitter, Uwe Christians, Dana Dabelea
BACKGROUND: Prenatal exposure to cannabis may influence childhood cognition and behavior, but the epidemiologic evidence is mixed. Even less is known about the potential impact of secondhand exposure to cannabis during early childhood. OBJECTIVE: This study sought to assess whether prenatal and/or postnatal exposure to cannabis was associated with childhood cognition and behavior. STUDY DESIGN: This sub-study included a convenience sample of 81 mother-child pairs from a Colorado-based cohort...
March 10, 2023: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/36945199/adult-adhd-diagnosis-symptoms-of-impulsivity-and-emotional-dysregulation-in-a-clinical-sample-of-outpatients-consulting-for-a-behavioral-addiction
#39
JOURNAL ARTICLE
Sarah El Archi, Servane Barrault, Manuel Garcia, Stéphanie Branger, Damien Maugé, Nicolas Ballon, Paul Brunault
OBJECTIVE: This study aimed to investigate ADHD in adult outpatients seeking treatment for a behavioral addiction and to identify the specificity of psychopathological features if the behavioral addiction cooccurs with adult ADHD. METHOD: Sixty-five outpatients consulting for a behavioral addiction were assessed for ADHD (DIVA-5), addictive disorder (alcohol, tobacco, cannabis, gambling, gaming, food, and sex), impulsivity (UPPS-P), and emotion dysregulation (DERS-36)...
March 21, 2023: Journal of Attention Disorders
https://read.qxmd.com/read/36943359/patient-experiences-with-prescription-cannabinoids-in-germany-protocol-for-a-mixed-methods-exploratory-and-anonymous-web-based-survey
#40
JOURNAL ARTICLE
Jan Moritz Fischer, Farid-Ihab Kandil, Matthias Karst, Laura Sophie Zager, Michael Jeitler, Felix Kugler, Franziska Fitzner, Andreas Michalsen, Christian S Kessler
BACKGROUND: Medical cannabinoids are controversial. Their use is comparatively rare, but it is rising. Since 2017, cannabinoids can be prescribed in Germany for a broader range of indications. Patient surveys on these drugs are hampered by the stigmatization of cannabinoids and their (still) low prevalence in medical contexts. Against this background, patients' willingness to provide information is limited. Moreover, it is logistically challenging to reach them with a survey. A thorough knowledge of currently ongoing therapies and their effects and side effects, however, is important for a more appropriate and effective use of cannabinoids in the future...
March 21, 2023: JMIR Research Protocols
keyword
keyword
34401
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.